ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 113 filers reported holding ALDEYRA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $126,953 | -20.4% | 19,005 | 0.0% | 0.00% | – |
| Q2 2023 | $159,452 | +59.5% | 19,005 | -15.5% | 0.00% | – |
| Q1 2022 | $99,977 | -9.9% | 22,492 | -18.6% | 0.00% | – |
| Q4 2021 | $111,000 | -53.4% | 27,645 | +2.2% | 0.00% | – |
| Q3 2021 | $238,000 | -25.6% | 27,061 | -4.2% | 0.00% | – |
| Q2 2021 | $320,000 | +259.6% | 28,251 | +84.8% | 0.00% | – |
| Q4 2019 | $89,000 | -8.2% | 15,284 | -9.5% | 0.00% | – |
| Q3 2019 | $97,000 | -4.0% | 16,887 | 0.0% | 0.00% | – |
| Q2 2019 | $101,000 | +10000.0% | 16,887 | +12048.9% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 139 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | -91.7% | 139 | -91.4% | 0.00% | – |
| Q3 2017 | $12,000 | +200.0% | 1,612 | +85.3% | 0.00% | – |
| Q2 2017 | $4,000 | -20.0% | 870 | -7.5% | 0.00% | – |
| Q1 2017 | $5,000 | 0.0% | 941 | 0.0% | 0.00% | – |
| Q4 2016 | $5,000 | -28.6% | 941 | 0.0% | 0.00% | – |
| Q3 2016 | $7,000 | +40.0% | 941 | 0.0% | 0.00% | – |
| Q2 2016 | $5,000 | +25.0% | 941 | 0.0% | 0.00% | – |
| Q1 2016 | $4,000 | +100.0% | 941 | +158.5% | 0.00% | – |
| Q3 2014 | $2,000 | – | 364 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
| Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
| Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
| Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
| Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
| Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
| Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
| Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
| APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |